Integrated multi-omics analysis identifies DARS2, MRTO4, and MRPL37 as novel biomarkers and potential therapeutic targets for bladder cancer
This research underscores the substantial functions of DARS2, MRTO4, and MRPL37 in the development of BC and their potential as therapeutic targets, offering a foundation for future investigations and the development of targeted therapies.
Authors
- Zhiliang Xiao
- Zhijie Zhuang
- 聡 三戸 (ORCID: https://orcid.org/0000-0002-2045-9375)
- Yuan Wang (ORCID: https://orcid.org/0000-0003-1575-4596)
- Lei Xiao (ORCID: https://orcid.org/0000-0002-0428-1749)
- Yujie Xiong (ORCID: https://orcid.org/0000-0002-1995-8257)
Institutions
- Central South University (CN)
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- The First People's Hospital of Changde (CN)
- Xiangya Hospital Central South University (CN)
- Loudi Central Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1007/s12672-025-04246-9
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00